NVCT - Nuvectis Pharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 285.25M
Enterprise value 269.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)22.93
Enterprise value/revenue N/A
Enterprise value/EBITDA -13.23

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 346.19%
S&P500 52-week change 314.65%
52-week high 317.82
52-week low 36.21
50-day moving average 315.44
200-day moving average 310.22

Share statistics

Avg vol (3-month) 335.35k
Avg vol (10-day) 360.05k
Shares outstanding 516.01M
Implied shares outstanding 6N/A
Float 85.64M
% held by insiders 158.11%
% held by institutions 119.91%
Shares short (30 May 2023) 4153.31k
Short ratio (30 May 2023) 42.86
Short % of float (30 May 2023) 42.06%
Short % of shares outstanding (30 May 2023) 40.96%
Shares short (prior month 27 Apr 2023) 4220.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-70.91%
Return on equity (ttm)-150.49%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-20.19M
Diluted EPS (ttm)-1.51
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.47M
Total cash per share (mrq)0.97
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.12
Book value per share (mrq)0.77

Cash flow statement

Operating cash flow (ttm)-15.26M
Levered free cash flow (ttm)-8.02M